2001 Marketing Pharmacy Testimonials 
Drug & Device Law
JULY 24, 2023
341 (2001). The drug is still on the market, and it has other risks that the FDA has found significantly more serious – requiring a boxed warning – than a three-one hundredths-of one-percent (0.0003) increase in absolute incidence of bladder cancer. the relationship between [plaintiff] and its pharmacy benefit manager. . .
Drug & Device Law
FEBRUARY 20, 2023
In product liability litigation generally, plaintiffs have been allowed to invent all kinds of “alternative” designs as long as some “expert” opines that the design (even if never before marketed) is “feasible.” For physicians to prescribe such a safer drug, it must reach the market. Wyeth Laboratories, Inc. , 2d 839, 851 (N.Y.
Expert insights. Personalized for you.
52 
Let's personalize your content